Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G.

Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

2.

Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.

Piccaluga PP, Rapezzi D, Gazzola A, Malagola M, Visani G, Gallamini A.

Bone Marrow Transplant. 2019 Jan;54(1):159-163. doi: 10.1038/s41409-018-0268-4. Epub 2018 Aug 16. No abstract available.

PMID:
30116015
3.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

4.

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.

Gallamini A, Tarella C, Viviani S, Rossi A, Patti C, Mulé A, Picardi M, Romano A, Cantonetti M, La Nasa G, Trentin L, Bolis S, Rapezzi D, Battistini R, Gottardi D, Gavarotti P, Corradini P, Cimminiello M, Schiavotto C, Parvis G, Zanotti R, Gini G, Ferreri AJM, Viero P, Miglino M, Billio A, Avigdor A, Biggi A, Fallanca F, Ficola U, Gregianin M, Chiaravalloti A, Prosperini G, Bergesio F, Chauvie S, Pavoni C, Gianni AM, Rambaldi A.

J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

PMID:
29360414
5.

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Graffigna G, Cecchini I, Breccia M, Capochiani E, Della Seta R, Galimberti S, Melosi A, Simonetti F, Pizzuti M, Capalbo SF, Falzetti F, Mazza P, Di Renzo N, Mastrullo L, Rapezzi D, Orlandi E, Intermesoli T, Iurlo A, Pungolino E, Pacilli M.

Qual Life Res. 2017 Oct;26(10):2739-2754. doi: 10.1007/s11136-017-1611-8. Epub 2017 Jun 12.

PMID:
28608152
6.

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Pieri L, Rossi E, Guglielmelli P, Betti S, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola E, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Barbui T.

Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

7.

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Breccia M, Graffigna G, Galimberti S, Iurlo A, Pungolino E, Pizzuti M, Maggi A, Falzetti F, Capalbo SF, Intermesoli T, Maffioli M, Elena C, Melosi A, Simonetti F, Capochiani E, Seta RD, Pacilli M, Luppi M, Di Renzo N, Mastrullo L, Trabacchi E, Vallisa D, Rapezzi D, Orlandi EM, Gambacorti-Passerini C, Efficace F, Alimena G.

Support Care Cancer. 2016 Nov;24(11):4487-93. doi: 10.1007/s00520-016-3286-z. Epub 2016 Jun 3.

PMID:
27260015
8.

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant'Antonio E, Vannucchi AM, Barbui T.

Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

PMID:
27113812
9.

Imatinib and ruxolitinib association: first experience in two patients.

Iurlo A, Gianelli U, Rapezzi D, Cattaneo D, Fermo E, Binda F, Santambrogio E, Bucelli C, Cortelezzi A.

Haematologica. 2014 Jun;99(6):e76-7. doi: 10.3324/haematol.2013.102525. Epub 2014 Mar 14. No abstract available.

10.

Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience.

Sorasio R, Bonferroni M, Grasso M, Strola G, Rapezzi D, Marenchino D, Di Marco C, Castellino C, Mattei D, Mordini N, Fiore F, Celeghini I, Borra A, Ghiglia A, Gallamini A.

Biol Blood Marrow Transplant. 2014 May;20(5):717-23. doi: 10.1016/j.bbmt.2014.02.002. Epub 2014 Feb 11.

11.

Cardiovascular events and intensity of treatment in polycythemia vera.

Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T; CYTO-PV Collaborative Group.

N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8.

12.

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.

Massi D, Fondi C, Nozzoli C, Benemei S, Lapi F, Albarello L, Avellini C, Bonoldi E, Casini M, Cesinaro AM, Ciceri F, Colombetti V, Comin CE, Donelli A, Fortunato M, Fratoni S, Guidi S, Messerini L, Milone G, Rapezzi D, Negri G, Patriarca F, Peccatori FA, Ponzoni M, Rafaniello P, Raimondi R, Salomone E, Tendas A, Villari L, Santucci M, Bosi A.

Hum Pathol. 2011 Feb;42(2):254-68. doi: 10.1016/j.humpath.2010.07.004. Epub 2010 Nov 24.

PMID:
21106223
13.

Long-term results of rituximab treatment for membranous nephropathy after allogeneic hematopoietic SCT: a case report.

Mattei D, Sorasio R, Guarnieri A, Marazzi F, Formica M, Fortunato M, Mordini N, Rapezzi D, Gallamini A.

Bone Marrow Transplant. 2010 Jun;45(6):1111-2. doi: 10.1038/bmt.2009.276. Epub 2009 Sep 28. No abstract available.

PMID:
19784075
14.

Acquired factor VIII inhibitor in patient infected with HIV: a casual association or a prone immunological setting?

Migliore E, Allione A, Dutto L, Bernardi E, Vettorazzi LA, Ricca M, Tartaglino B, Rapezzi D, Grasso M.

Haemophilia. 2009 Nov;15(6):1334-5. doi: 10.1111/j.1365-2516.2009.02083.x. Epub 2009 Jul 30. No abstract available.

PMID:
19659600
15.

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.

Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A.

Bone Marrow Transplant. 2009 Jun;43(12):967-8. doi: 10.1038/bmt.2008.415. Epub 2008 Dec 22. No abstract available.

PMID:
19104491
16.

Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient.

Mattei D, Bassan R, Mordini N, Rapezzi D, Rambaldi A, Strola G, Peretti C, Del Grosso F, Ferraris AM, Castellino C, Gallamini A.

Bone Marrow Transplant. 2007 Aug;40(3):283-5. Epub 2007 May 28. No abstract available.

PMID:
17529999
17.

Clonal granulocytes in polycythaemia vera and essential thrombocythaemia have shortened telomeres.

Ferraris AM, Pujic N, Mangerini R, Rapezzi D, Gallamini A, Racchi O, Casciaro S, Gaetani GF.

Br J Haematol. 2005 Aug;130(3):391-3.

PMID:
16042688
18.
19.

False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.

Mattei D, Rapezzi D, Mordini N, Cuda F, Lo Nigro C, Musso M, Arnelli A, Cagnassi S, Gallamini A.

J Clin Microbiol. 2004 Nov;42(11):5362-3.

20.

High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia.

Ferraris AM, Mangerini R, Pujic N, Racchi O, Rapezzi D, Gallamini A, Casciaro S, Gaetani GF.

Blood. 2005 Mar 1;105(5):2138-40. Epub 2004 Oct 19.

21.

Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.

Morabito F, Mangiola M, Rapezzi D, Zupo S, Oliva BM, Ferraris AM, Spriano M, Rossi E, Stelitano C, Callea V, Cutrona G, Ferrarini M.

Haematologica. 2003 Aug;88(8):864-73.

22.

Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma.

Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF.

Eur J Haematol. 2003 Apr;70(4):225-30.

PMID:
12656745
23.

Exposure of erythrocytes to methylene blue shows the active role of catalase in removing hydrogen peroxide.

Gaetani GF, Rapezzi D, Mangerini R, Racchi O, Rolfo M, Ferraris AM.

Br J Haematol. 2002 Dec;119(3):833-8.

PMID:
12437668
24.

Histological subtypes of Hodgkin's disease in the setting of HIV infection.

Rapezzi D, Ugolini D, Ferraris AM, Racchi O, Gaetani GF.

Ann Hematol. 2001 Jun;80(6):340-4.

PMID:
11475147
25.

Megathrombocytes and spurious thrombocytopenia.

Racchi O, Rapezzi D.

Eur J Haematol. 2001 Feb;66(2):140-1. No abstract available.

PMID:
11168524
26.

Mutations of the HFE gene and the risk of hepatocellular carcinoma.

Racchi O, Mangerini R, Rapezzi D, Gaetani GF, Nobile MT, Picciotto A, Ferraris AM.

Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):350-3.

PMID:
10660482
27.

Heterogeneity of clonal development in chronic myeloproliferative disorders.

Ferraris AM, Mangerini R, Racchi O, Rapezzi D, Rolfo M, Casciaro S, Gaetani GF.

Am J Hematol. 1999 Feb;60(2):158-60.

28.

X chromosome inactivation patterns in normal females.

Racchi O, Mangerini R, Rapezzi D, Rolfo M, Gaetani GF, Ferraris AM.

Blood Cells Mol Dis. 1998 Dec;24(4):439-47.

PMID:
9880240
29.

Survival of people who are HIV-1-positive and G6PD-deficient is unaffected by virus-induced oxidative stress.

Rapezzi D, Porqueddu EM, Fenu L, Racchi O, Ferraris AM, Gaetani GF, Aceti A.

Lancet. 1998 Jan 24;351(9098):264-5. No abstract available.

PMID:
9457100
30.

Perirenal extramedullary hematopoiesis in agnogenic myeloid metaplasia: MR imaging findings.

Rapezzi D, Racchi O, Ferraris AM.

AJR Am J Roentgenol. 1997 May;168(5):1388-9. No abstract available.

PMID:
9129461
31.

Familial Hodgkin's disease: a disease of young adulthood?

Ferraris AM, Racchi O, Rapezzi D, Gaetani GF, Boffetta P.

Ann Hematol. 1997 Mar;74(3):131-4. Review.

PMID:
9111426
32.

Unusual bone marrow relapse of Hodgkin's disease with typical Pel-Ebstein fever.

Racchi O, Rapezzi D, Ferraris AM, Gaetani GF.

Ann Hematol. 1996 Jul;73(1):39-40.

PMID:
8695723

Supplemental Content

Loading ...
Support Center